Search research articles
Contact Us
Filters
Showing results (101-110 of 120) with videos related to
Page
of 12
Sort By:
NPJ Vaccines
|
April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
NPJ Vaccines
|
November 7, 2021
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
NPJ Vaccines
|
March 19, 2023
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
Shikha Shrivastava, Joshua M Carmen, Zhongyan Lu, et al.
Plos Pathogens
|
September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
NPJ Vaccines
|
December 19, 2025
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates
Shikha Shrivastava, Joshua M Carmen, Jiae Kim, et al.
Vaccines
|
October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection
Agnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Cell Reports. Medicine
|
April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
Jingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Science Advances
|
November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN
Jingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 120) with videos related to
Sort By:
Page
of 12
NPJ Vaccines
|
April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
NPJ Vaccines
|
November 7, 2021
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
NPJ Vaccines
|
March 19, 2023
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
Shikha Shrivastava, Joshua M Carmen, Zhongyan Lu, et al.
Plos Pathogens
|
September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
The Lancet. Microbe
|
May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
NPJ Vaccines
|
December 19, 2025
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates
Shikha Shrivastava, Joshua M Carmen, Jiae Kim, et al.
Vaccines
|
October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection
Agnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Cell Reports. Medicine
|
April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
Jingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Science Advances
|
November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN
Jingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Page
of 12